Thymosin

【Product name】ZADAXIN, THYMIN(RG)

[English common name]Thymosin

[Chinese common name]Thymosin

[English name]Thymin

[Chinese other name]Thymosin

[indications]
Chronic hepatitis B 
This product is used to treat patients with chronic hepatitis B over the age of 18, and the patient's liver disease is compensatory and has hepatitis B virus replication (serum HBV-DNA positive), in those serum hepatitis B surface antigen (HBsAg) positive Studies in patients with a minimum of 6 months and elevated serum aminotransferase (ALT) have shown that treatment with this product can produce viral remission (serum HBV-DNA loss) and retransferase levels. In some responding patients, the drug treatment removes serum surface antigens. Clinical trials suggest that when this drug is combined with alpha interferon, it may have a higher response rate than the drug alone or with interferon alone.
An immunopotentiator for immunocompromised patients 
The immune system is inhibited, including those who receive chronic hemodialysis and elderly patients. This medicine can enhance the immune response of patients to viral vaccines such as influenza vaccine or hepatitis B vaccine. Studies on hemodialysis patients have shown that 65% of patients who took this drug as an adjuvant had an anti-influenza antibody titer level that increased more than four-fold after flu vaccine, and only 24% of patients in the placebo group responded.

【Dosage】
This product should not be used for intramuscular or intravenous injection. It should be subcutaneously injected immediately after dissolution with 1.0 ml of water for injection in the box. Dosages can be used as directed by your doctor.
Chronic hepatitis B This product is recommended for the treatment of chronic hepatitis B. The subcutaneous injection of 1.6 mg per needle is twice a week, and the two doses are approximately 3-4 days apart. Treatment should be uninterrupted for 6 months (52 needles).
If this product is used in combination with alpha interferon, the dose and precautions in the alpha interferon prescription data should be consulted. In a combined clinical trial, when the two drugs are used on the same day, the product is usually administered in the morning and the interferon is administered at night.
As a vaccine booster for immunocompromised patients, this product is used as a viral vaccine enhancer. The recommended dose is 1.6mg subcutaneous injection, twice a week, 3 to 4 days apart, and the course of treatment should last 4 weeks (8 needles in total). The first needle should be given immediately after vaccination.
The physician decides whether to teach the patient to self-inject.

[Storage]Sealed, shading, stored at 2-8 ° C (36 ° ~ 46 ° F), immediately after preparation.

[Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

Description

name

Attention: The internal data of table “549” is corrupted!

product

Attention: The internal data of table “550” is corrupted!

product manual

Product information